ARTICLE | Company News
SkyePharma and Sanofi launch Xatral in Europe
April 12, 2000 7:00 AM UTC
SkyePharma (LSE:SKP; SKYE) and partner Sanofi- Synthelabo (Paris, France) launched Xatral XL, a sustained release once daily formulation of alfuzosin in Denmark, Sweden, the Netherlands and the U.K. X...